CTMX vs AAPL: Which Stock is Better?
Side-by-side comparison of Cytomx Therapeutics Inc and Apple Inc in 2026
CTMX
Cytomx Therapeutics Inc
$4.68
AAPL
Apple Inc
$256.90
Key Metrics Comparison
| Metric | CTMX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $792.96M | N/A | CTMX |
| P/E Ratio | 16.14 | 33.85 | CTMX |
| EPS (TTM) | $0.29 | $7.55 | AAPL |
| Revenue Growth | -0.8% | 6.4% | AAPL |
| Gross Margin | 100.0% | 46.9% | CTMX |
Analyze CTMX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CTMX or AAPL a better investment?
Comparing CTMX and AAPL: Cytomx Therapeutics Inc has a market cap of $792.96M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CTMX and AAPL?
CTMX (Cytomx Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CTMX or AAPL?
Based on P/E ratios, CTMX trades at a lower multiple (16.1x vs 33.8x).
Which is growing faster: CTMX or AAPL?
AAPL has higher revenue growth at 6.4% vs -0.8% for CTMX.
Which company is more profitable: CTMX or AAPL?
Cytomx Therapeutics Inc (CTMX) has higher gross margins at 100.0% compared to 46.9% for AAPL.
Which is the larger company: CTMX or AAPL?
Cytomx Therapeutics Inc (CTMX) is larger with a market cap of $792.96M compared to N/A for AAPL.
Should I buy CTMX or AAPL in 2026?
Both CTMX and AAPL have investment merit. CTMX trades at $4.68 while AAPL trades at $256.90. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CTMX and AAPL stock?
Key differences: Market Cap ($792.96M vs N/A), P/E Ratio (16.1x vs 33.8x), Revenue Growth (-0.8% vs 6.4%), Gross Margin (100.0% vs 46.9%).